跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 毓志
Doctor
小兒部
電子郵件
ped1
mail.ncku.edu
tw
h-index
2311
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1993 …
2025
每年研究成果
概覽
指紋
網路
研究成果
(71)
類似的個人檔案
(6)
指紋
查看啟用 Yuh-Jyh Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Agenesis
19%
Assisted Ventilation
24%
Bilirubin
19%
Body Weight
22%
Branchiogenic Cyst
19%
Candidemia
19%
Cerebral Hemorrhage
19%
Congenital Adrenal Hyperplasia
19%
Congenital Hyperinsulinism
19%
Corticosteroid Therapy
19%
Dexamethasone
24%
Diaphragm
19%
Extremely Low Birth Weight
19%
Foramen Magnum
19%
Gestational Age
38%
Health Outcomes
19%
Health Service
19%
Hospital Delivery
19%
Hyperinsulinemic Hypoglycemia
12%
Hypoglycemia
19%
Ibuprofen
19%
Kyphosis
19%
Ligation
16%
Lung Dysplasia
19%
Maturation
19%
Neonatal Infant
47%
Neonatal Intensive Care Unit
17%
Neonatal Respiratory Distress Syndrome
19%
Newborn Intensive Care
19%
Newborn Morbidity
26%
Newborn Screening
19%
Patent Ductus Arteriosus
38%
Pervasive Developmental Disorder
19%
Phonation
19%
Physiological Response
19%
Prematurity
37%
Quality Improvement
21%
Randomized Clinical Trial
19%
Respiratory Syncytial Virus
19%
Retinopathy of Prematurity
19%
Retrospective Cohort Study
24%
Severe Combined Immunodeficiency
19%
Silo-Filler's Disease
19%
Small for Gestational Age
19%
Spondylitis
19%
Supraventricular Tachycardia
19%
Survival Rate
19%
T Lymphocyte Receptor
19%
Tracheal Intubation
19%
Very Low Birth Weight
100%
Keyphrases
Apnea of Prematurity
19%
Bevacizumab Therapy
19%
Center Experience
19%
Chronic Lung Disease
19%
Common Reference
19%
Congenital Adrenal Hyperplasia
19%
Delayed Start
19%
Delivery Hospital
19%
Dosing Recommendations
19%
Early Postnatal
19%
Exhaled Nitric Oxide
19%
Extremely Low Birth Weight Infants
19%
Fetal Tachycardia
19%
Foramen Magnum
19%
Growth Outcomes
19%
Hydrops
19%
Intravitreal Bevacizumab
19%
Long-term Characteristics
19%
Lung Disease
19%
Lung Growth
19%
Machine Learning
19%
Mediastinal Abscess
19%
Morbidity Outcome
19%
Multicenter Clinical Trial
19%
Neonatal Treatment
19%
Neuroprogenitor Cells
19%
Newborn Intensive Care Unit
19%
Noise Sensor
19%
Nomogram
19%
Noninvasive Positive Pressure Ventilation
19%
Peak Factor
19%
Persistent Hyperinsulinemic Hypoglycemia of Infancy
19%
Placenta Accreta
19%
Posterior Mediastinal
19%
Preterm Infants
38%
Prolonged Hypoglycemia
19%
Pulmonary Outcomes
19%
Quality Improvement Study
19%
Respiratory Distress Syndrome
38%
Retrospective Cohort Study
19%
School Age
19%
Seasonal Risk
19%
Sick Newborn
19%
Single-center Experience
19%
Single-center Study
19%
Sound Level
19%
Squamous Suture
19%
Transcutaneous Bilirubin
38%
Vaginal pH
19%
VEGF Receptor Inhibitor
19%
Nursing and Health Professions
Acidemia
6%
Birth Weight
40%
Body Height
6%
Body Weight
24%
Bottle Feeding
19%
Brain Hemorrhage
5%
Cardiorespiratory
19%
Cell Count
5%
Chronic Lung Disease
5%
Dexamethasone
19%
Drug Formulary
6%
Endotracheal Tube
6%
Eosinophil Count
8%
Extremely Low Birth Weight
19%
Gestational Age
26%
Healthcare Associated Infection
19%
Hospital Discharge
19%
Hyaline Membrane Disease
5%
Incubator
11%
Infant Feeding
19%
Infant Mortality
6%
Intensive Care
19%
Leukotriene B4
5%
Live Birth
8%
Lung Disease
19%
Mortality Rate
31%
National Health Insurance
19%
Necrotizing Enterocolitis
5%
Neonatal Intensive Care Unit
24%
Neutrophil Count
5%
Newborn Mortality
21%
Oxygen Desaturation
24%
Oxygen Saturation
24%
Palivizumab
19%
Patent Ductus Arteriosus
5%
Placenta Previa
19%
Prematurity
19%
Recommended Drug Dose
6%
Regionalization
6%
Retrolental Fibroplasia
5%
Sepsis
5%
Soft Tissue Infection
6%
Sound Intensity
19%
Tertiary Care Center
11%
Tracheal Aspiration Procedure
5%
Very Low Birth Weight
38%
